Your browser doesn't support javascript.
loading
Protocol for an interdisciplinary cross-sectional study investigating the social, biological and community-level drivers of antimicrobial resistance (AMR): Holistic Approach to Unravel Antibacterial Resistance in East Africa (HATUA).
Asiimwe, Benon B; Kiiru, John; Mshana, Stephen E; Neema, Stella; Keenan, Katherine; Kesby, Mike; Mwanga, Joseph R; Sloan, Derek J; Mmbaga, Blandina T; Smith, V Anne; Gillespie, Stephen H; Lynch, Andy G; Sandeman, Alison; Stelling, John; Elliott, Alison; Aanensen, David M; Kibiki, Gibson E; Sabiiti, Wilber; Holden, Matthew T G.
Afiliación
  • Asiimwe BB; School of Biomedical Sciences, Makerere University, Kampala, Uganda.
  • Kiiru J; Centre for Microbiology Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Mshana SE; Department of Microbiology and Immunology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
  • Neema S; College of Humanities and Social Science, Makerere University, Kampala, Uganda.
  • Keenan K; Geography and Sustainable Development, University of St Andrews, St Andrews, Fife, UK katherine.keenan@st-andrews.ac.uk.
  • Kesby M; Geography and Sustainable Development, University of St Andrews, St Andrews, Fife, UK.
  • Mwanga JR; School of Public Health, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
  • Sloan DJ; School of Medicine, University of St Andrews, St Andrews, UK.
  • Mmbaga BT; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre and Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Smith VA; School of Biology, University of St Andrews, St Andrews, UK.
  • Gillespie SH; School of Medicine, University of St Andrews, St Andrews, UK.
  • Lynch AG; School of Medicine, University of St Andrews, St Andrews, UK.
  • Sandeman A; School of Mathematics and Statistics, University of St Andrews, St Andrews, UK.
  • Stelling J; School of Medicine, University of St Andrews, St Andrews, UK.
  • Elliott A; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Aanensen DM; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.
  • Kibiki GE; Immunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Institute, Kampala, Uganda.
  • Sabiiti W; Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Cambridge, UK.
  • Holden MTG; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
BMJ Open ; 11(3): e041418, 2021 03 08.
Article en En | MEDLINE | ID: mdl-34006022
ABSTRACT

INTRODUCTION:

Antimicrobial resistance (AMR) is a global health threat that requires urgent research using a multidisciplinary approach. The biological drivers of AMR are well understood, but factors related to treatment seeking and the social contexts of antibiotic (AB) use behaviours are less understood. Here we describe the Holistic Approach to Unravel Antibacterial Resistance in East Africa, a multicentre consortium that investigates the diverse drivers of drug resistance in urinary tract infections (UTIs) in East Africa. METHODS AND

ANALYSIS:

This study will take place in Uganda, Kenya and Tanzania. We will conduct geospatial mapping of AB sellers, and conduct mystery client studies and in-depth interviews (IDIs) with drug sellers to investigate AB provision practices. In parallel, we will conduct IDIs with doctors, alongside community focus groups. Clinically diagnosed patients with UTI will be recruited from healthcare centres, provide urine samples and complete a questionnaire capturing retrospective treatment pathways, sociodemographic characteristics, attitudes and knowledge. Bacterial isolates from urine and stool samples will be subject to culture and antibiotic sensitivity testing. Genomic DNA from bacterial isolates will be extracted with a subset being sequenced. A follow-up household interview will be conducted with 1800 UTI-positive patients, where further environmental samples will be collected. A subsample of patients will be interviewed using qualitative tools. Questionnaire data, microbiological analysis and qualitative data will be linked at the individual level. Quantitative data will be analysed using statistical modelling, including Bayesian network analysis, and all forms of qualitative data analysed through iterative thematic content analysis. ETHICS AND DISSEMINATION Approvals have been obtained from all national and local ethical review bodies in East Africa and the UK. Results will be disseminated in communities, with local and global policy stakeholders, and in academic circles. They will have great potential to inform policy, improve clinical practice and build regional pathogen surveillance capacity.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research Límite: Humans País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Uganda

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research Límite: Humans País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Uganda